NHS England

Key Findings

• Economic: NHS England’s documented nexus is its civilian Federated Data Platform procurement from a Palantir-led consortium, worth up to £330 million over a maximum seven years; Palantir separately disclosed an Israeli Ministry of Defence partnership. The records do not identify NHS England as a party to that defence agreement.^{1, 2}
• Digital: Government disclosures confirm authorised supplier access to NHS England’s National Data Integration Tenant, including three Palantir engineers with administrative permissions. Documentation deficiencies prompted an apology and correction commitments, but did not themselves establish unauthorised access or disclosure to Israel.^{3, 4}
• Political: Parliamentary committees and civil society organisations challenged the Palantir procurement. Separately, government records document specialist NHS treatment for children evacuated from Gaza, including 50 children supported through the evacuation programme during 2025.^{5, 6, 7}
• Not found: No public evidence identified in the reviewed records of NHS England directly supplying Israeli military bodies, transferring NHS patient data to them, or operating or financing Israeli settlements.^{8, 9, 10, 11}

Target Profile

Executive Summary

NHS England’s documented Israel/Palestine nexus centres on the Federated Data Platform (FDP), a civilian healthcare information programme awarded in November 2023 to a consortium led by Palantir. The arrangement has a reported maximum value of approximately £330 million over a possible seven-year term. Its documented purposes include healthcare data integration, waiting-list management, discharge coordination and operational planning. The programme was operational from 2024 and remained live in August 2026.^{9, 1}

The relevant supplier connection is substantive but indirect. Palantir’s 2024 Form 10-K disclosed a strategic partnership with Israel’s Ministry of Defence to provide technology supporting wartime activities. This establishes a separate defence relationship within the same supplier group. It does not identify NHS England as a party, subcontractor or operator, and the audits found no identifiable transfer of NHS contract receipts to that defence programme. Palantir’s September 2025 response acknowledged Israeli civil, defence and intelligence mandates while denying involvement in the Lavender and The Gospel targeting systems.^{2, 16}

Digital governance concerns are independently documented. Government disclosures identified authorised external access to NHS England’s National Data Integration Tenant (NDIT), including three Palantir engineers with administrative access and a separate group of 33 engineers with project-specific permissions. Published assessment language had inaccurately described access arrangements, prompting an apology and correction commitments. These findings qualify broad assurances about supplier access, but do not establish unauthorised extraction, Israeli government access or military use of NHS information. Government-reported access audits supplied assurances whose underlying technical records were not independently available in the reviewed material.^{3, 4, 17}

Political scrutiny concerns procurement choices, patient confidence, supplier dependence and the evidence supporting claimed benefits. Parliamentary committees recommended discontinuing the arrangement, while Amnesty International, Medact and Healthcare Workers for a Free Palestine campaigned against it because of Palantir’s separate military activities. These recommendations and campaigns did not themselves terminate the contract or establish NHS England’s participation in Israeli operations. The record also includes NHS treatment for children evacuated from Gaza under a government-coordinated humanitarian programme.^{5, 6, 7}

The fixed, human-vetted V6.6 result is BRS 0, Tier E (Minimal/No Complicity). The audits establish a contested civilian supplier relationship, while identifying no public evidence of direct NHS England military supply, provision of digital capabilities to Israeli authorities, settlement operations, Israeli investment or political financing supporting Israeli military or settlement activity. The zero scores preserve those attribution boundaries; they do not resolve the separate questions about procurement quality, transparency or public trust.^{8, 9, 10, 2, 11}

Timeline of Relevant Events

Corporate Overview

NHS England is a UK statutory public healthcare institution. Its public accounts and institutional descriptions establish national healthcare responsibilities and public accountability rather than a shareholder-controlled multinational structure. The government proposed transferring its functions into the Department of Health and Social Care by March 2027, subject to parliamentary approval. The reviewed September–October 2026 material did not establish that dissolution or transfer had already been completed.^{8, 15, 12}

The 2023 integrations of NHS Digital and Health Education England consolidated UK public functions. No public evidence identified in the audits of an Israeli subsidiary, controlling Israeli affiliate, Israeli operating establishment or franchise relationship arising from these changes. NHS-wide activity also requires organisation-specific attribution: individual trusts, foundation trusts and integrated care boards cannot automatically be treated as NHS England itself.^{11, 18, 19, 28}

The FDP consortium includes Palantir, Accenture, PwC, Carnall Farrar and NECS. NHS England separately awarded a privacy-enhancing technology contract to IQVIA. NHS England controls its national FDP instance, while participating trusts and integrated care boards control their respective instances. These are procurement and implementation arrangements, not evidence that consortium participants’ overseas activities are NHS England operations.^{9, 10}

Domain Summaries

Military: Military

Mechanism of Involvement

The identified military-adjacent mechanism is shared-supplier procurement. NHS England purchases civilian healthcare technology from Palantir’s UK entity; the wider Palantir group separately supplies defence-related technology to Israel. Palantir’s financial disclosure and its September 2025 correspondence establish the supplier’s defence connection, while the NHS programme’s published purposes remain healthcare administration and operational planning.^{9, 2, 16}

Amnesty’s campaign treats that commercial relationship as grounds for ending the NHS contract. The audit records the objection as an argument about supplier selection and continued procurement, without converting it into evidence that NHS England supplies weapons, military logistics or targeting systems.^{20, 5}

No public evidence identified of NHS England contracting directly with Israel’s Ministry of Defence, armed forces, intelligence organisations, prison service or Border Police for military support. The reviewed record likewise identified no NHS England provision of weapons, munitions, military components, base services, construction machinery or military-purpose AI to Israeli end-users.^{8, 2, 20}

Counter-Arguments and Evidence Limits

The strongest defence is the contract’s civilian purpose and the absence of an evidenced military end-user connection. A supplier’s separate defence business does not establish that the NHS customer commissioned, controlled or supplied that work. No public evidence identified that the FDP provides military targets or forms part of an Israeli weapons system.^{9, 2, 16}

Palantir expressly denied developing or supplying Lavender and The Gospel. That denial does not independently settle every allegation concerning its wider military business, but it must accompany discussion of the disputed systems. The audits do not establish the particular Israeli military products or modules sufficiently to attribute a specific targeting function to NHS England’s procurement.^{16, 20}

The procurement relationship continued after the audits’ July and November 2024 chronology thresholds. Continuation establishes an ongoing civilian commercial relationship, rather than an independently demonstrated NHS decision to support Israeli military operations. No public evidence identified of an NHS England arms-export enforcement action or direct military-supply proceeding in the reviewed institutional and regulatory material.^{9, 11, 29}

Named Entities and Evidence Map

Digital: Digital

Mechanism of Involvement

The FDP is national healthcare infrastructure combining integration, analytics, operational applications and cloud data warehousing. NHS England funds licences and support for participating trusts and integrated care boards. Its civilian use cases include waiting lists, patient flow, discharge planning and organisational reporting.⁹

Supplier access requires precise description. The government’s 22 October 2026 response identified three Palantir engineers with administrative-level NDIT access. Separately, 33 engineers held more restricted project-specific access as at 15 June: 12 from Palantir, eight Mastek, five Capgemini, four IBM, three Kainos and one Qualitest. The administrative group was additional to those 33. Government explanations described configuration, security, maintenance, development and assurance functions under NHS England’s instructions.³

Reporting also documented that NDIT contained patient information before pseudonymisation. NHS England apologised after published assessment wording failed to accurately reflect authorised external access. This was a material transparency deficiency, carried here without inferring an unproven transfer to Israel.⁴

Counter-Arguments and Evidence Limits

The National Data Guardian reported contractual limits on supplier control, independent use and sharing of NHS information. These protections support the civilian processing explanation, but contractual restrictions alone do not independently verify every technical access pathway. The later access disclosures therefore qualify any categorical suggestion that supplier personnel could never access identifiable information.^{10, 3, 4}

The department reported that audits confirmed permissions matched approved access, relevant projects, continuing operational need and current security clearance. These are government-reported assurances; the reviewed answer did not publish underlying logs or independently verified technical findings. Neither the documentation correction nor those assurances establish data extraction or disclosure to Israeli authorities.¹⁷

No public evidence identified of Israeli government access to the FDP, identifiable FDP data processing in Israeli data centres, NHS participation in Project Nimbus, or NHS provision of offensive cyber tools, surveillance systems or military AI to Israeli bodies. No public evidence identified of the named Israeli-origin enterprise and biometric vendors being deployed through the examined national FDP arrangements.^{9, 10}

Freedom-of-information findings must also retain their proper scope. The ICO identified a 2021 response-deadline breach, upheld a DHSC policy-development exemption in March 2026 and rejected certain commercial-confidence withholding of invoice pricing in April 2026. These concern disclosure obligations; they do not establish unlawful transfer of NHS data to Israel.^{30, 29, 31}

Named Entities and Evidence Map

Economic: Economic

Mechanism of Involvement

The verified economic link is a substantial public procurement relationship with Palantir’s corporate group. The approximately £330 million figure is the maximum potential value over seven years, not an established amount already paid. The audits separately record an initial published value of £182,242,760 and award date of 22 November 2023. These figures describe different contractual measures and should not be conflated.^{1, 11, 26}

Palantir’s 2024 filing confirms its Israeli defence partnership and states that then-current operations related to Ukraine and Israel were not material to its financial position or operating results. Neither disclosure quantifies NHS-derived funding for Israeli activities. No public evidence identified of an identifiable onward allocation of NHS receipts to Israel’s Ministry of Defence.²

No public evidence identified of NHS England-owned Israeli businesses, factories, research centres, property, payroll or settlement operations. The audits also identified no NHS England holdings in Israeli sovereign debt, Israel Bonds, Israeli venture funds or defence manufacturers, and no verified direct procurement of Israeli settlement-origin goods.^{8, 11, 12}

Counter-Arguments and Evidence Limits

The strongest defence is the absence of a demonstrated target-specific economic flow to Israeli military or settlement activity. A purchase from a multinational supplier establishes commercial exposure to that supplier; it does not establish the destination of particular receipts. The maximum contract ceiling cannot be presented as money transferred to Israel.^{2, 11}

Healthcare procurement attribution is equally important. Individual hospital or trust purchases require contractual or accounting evidence before being assigned to NHS England. Local FDP implementation also differs: Manchester’s council record distinguished integrated-care-board decisions from adoption by individual trusts.^{11, 28}

Value-for-money questions remain separate and unresolved. The statistics regulator found that observational before-and-after comparisons could not establish causation. An independent Imperial College London evaluation had been commissioned, but commissioning did not establish demonstrated benefits. The National Audit Office’s broader patient-record integration study was work in progress, not a completed adverse finding on Palantir’s contract.^{23, 32}

The precise initial-period end date also remains qualified. The procurement record supports 15 February 2027, while a ministerial explanation describes March 2027. The record does not conclusively reconcile the discrepancy or establish a separate exact deadline for contractual notice.^{26, 27}

Named Entities and Evidence Map

Political: Political

Mechanism of Involvement

The principal political record is scrutiny directed at NHS England’s procurement. Amnesty and partner organisations called for termination in March 2026; Manchester City Council considered a September motion; nationwide demonstrations followed in October. Parliamentary committees also recommended discontinuation and preparation of alternatives, citing mistrust, security concerns, uncertain benefits and competing technologies.^{5, 11, 7, 24}

These interventions establish organised opposition and institutional scrutiny. They do not establish NHS England advocacy for Israeli territorial policy or a direct donation to Israel’s defence establishment. No public evidence identified of NHS England lobbying for settlements, financing military-welfare organisations or issuing a verified institutional endorsement of Israeli military operations.^{8, 5, 11}

The humanitarian record provides relevant exculpatory context. Government announcements document specialist NHS care in the United Kingdom for children evacuated from Gaza. In June 2026, the government reported support for 50 children during 2025 and announced further evacuations. These were government-coordinated clinical arrangements, not an independently issued political declaration by NHS England’s leadership.^{21, 22, 6}

Counter-Arguments and Evidence Limits

The strongest defence is NHS England’s civilian statutory mission and the absence of evidenced pro-military political conduct. The documented humanitarian treatment of Palestinian children must be included alongside procurement criticism. Treatment in UK hospitals does not establish an NHS England-operated facility in Gaza or the West Bank.^{21, 22, 6, 12}

The Lord Mann review requires particular care. It recommended clearer national guidance on political identifiers, uniforms, branding and official social-media profiles, discussing both “Free Palestine” and “I love Israel”. It also addressed antisemitism and other racism. Recommendations and examples of local trust rules do not establish that NHS England implemented every restriction nationally or systematically disciplined staff for supporting Palestinian civilians.³³

No public evidence identified in the reviewed record of a headquarters-level dismissal or adjudicated disciplinary case specifically concerning pro-Palestinian expression. Likewise, scrutiny of FDP benefits or leadership accountability does not establish that NHS England executives directed or financed Palantir’s separate Israeli defence work.^{5, 7, 33}

Committee recommendations and council motions were requests and scrutiny, not binding termination decisions or judgments of military complicity. The audits do not establish a specific post-November 2024 NHS England authorisation of Israeli military assistance.^{11, 7}

Named Entities and Evidence Map

Complicity Index Score

Method: V6.6 - final, human-vetted values.

• V_MAX: 0.00 Avg_OTHERS: 0.00
• BRS Score: 0 Tier: E (Minimal/No Complicity)

V_MAX and Avg_OTHERS are zero because all four fixed domain scores are zero: the audited civilian procurement relationship does not establish NHS England participation in its supplier’s separate Israeli defence activities.^{9, 2} The resulting BRS 0 and Tier E preserve the absence of evidenced direct military, digital, economic or political involvement identified by the audits.^{8, 10, 11} This scale-free, evidence-only, human-vetted result does not turn procurement controversy or unresolved governance questions into findings of complicity.

Methodology Note

• This dossier compiles only the four supplied domain audits, with an evidence cut-off of 26 October 2026. It does not claim fresh source verification.
• Under V6.6, scale-free Impact (I) concerns activity type, Magnitude (M) concerns scale, and Proximity (P) concerns directness. The supplied final values are reproduced unchanged.
• Temporal attribution distinguishes historical, continuing and prospective activity. Divested or exited operations must be mitigated where documented; proposed transfers, recommendations and review opportunities are not treated as completed actions.
• Entity attribution requires evidence connecting conduct to NHS England. Supplier-group activities, government policy and individual NHS organisations’ transactions do not create transitive responsibility.
• Verified settlement operations would be considered under both Economic and Political. No public evidence identified of such NHS England operations in the supplied audits.
• “No public evidence identified” denotes the outcome of the audits’ reviewed checks, not proof that an activity could never exist. Unresolved dates, disputed allegations, reported safeguards and incomplete evaluations retain their stated limitations.